Grant chasers... Sounds like US DOD is happy with us so far,...

Grant chasers...

Sounds like US DOD is happy with us so far, that's all that matters...

Will be happy to see another $4 mill USD in the coffers anyways..

TCG

"• Immuron’s request for AU$5.4M (US$4M) additional funding from the U.S. Department of Defense for Travelan considered to be ‘eligible for award’
• Travelan Investigational New Drug (IND) application advances

• Clinical trial Synopsis complete and plans in place to conduct a controlled human infection model (CHIM) clinical trial in 60 healthy volunteers in the USA Melbourne, Australia, April 19, 2022: Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the prevention and treatment of gut mediated pathogens, is pleased to advise that a new request for funding has been considered to be eligible for award by the US Department of Defense funding body ‘Medical Technology Enterprise Consortium’ (MTEC). Immuron is pursuing a regulatory pathway to license Travelan® with the Food and Drug Administration (FDA) via a Biologics License Application (BLA). The proposed indication is to reduce the risk of contracting travelers’ diarrhea caused by bacterial pathogens. The Company was recently awarded AU$4.8M (US$3.43M) by MTEC for the development of a Travelan® dosing regimen acceptable for use by the US military (ASX announcement 12 January 2022). In this new MTEC request for funding, Immuron is seeking an additional US$4M to fund the Investigational New Drug Application, CMC Assay Development and Validation, Nonclinical Safety Studies and Stability Studies required to support the BLA."